US Stock MarketDetailed Quotes

BRTX Biorestorative Therapies

Watchlist
  • 1.300
  • +0.070+5.69%
Trading Apr 26 13:08 ET
8.80MMarket Cap-380P/E (TTM)

Biorestorative Therapies Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
21.70%145.8K
421.62%19.3K
5.86%30.7K
-9.28%64.5K
95.63%31.3K
160.43%119.8K
-26.00%3.7K
262.50%29K
374.00%71.1K
-11.11%16K
Operating revenue
21.70%145.8K
421.62%19.3K
5.86%30.7K
-9.28%64.5K
95.63%31.3K
160.43%119.8K
-26.00%3.7K
262.50%29K
374.00%71.1K
-11.11%16K
Cost of revenue
Gross profit
Operating expense
-19.49%15.28M
-29.44%3.24M
-34.21%3.05M
-32.31%3.18M
14.99%5.81M
-27.97%18.98M
14.39%4.59M
25.48%4.64M
31.64%4.7M
-66.47%5.05M
Selling and administrative expenses
-27.27%11.33M
-36.21%2.56M
-38.07%2.26M
-38.94%2.21M
0.11%4.3M
-39.20%15.58M
4.24%4.01M
5.50%3.65M
6.31%3.62M
-71.19%4.29M
-General and administrative expense
-27.27%11.33M
-36.21%2.56M
-38.07%2.26M
-38.94%2.21M
0.11%4.3M
-39.20%15.58M
4.24%4.01M
5.50%3.65M
6.50%3.62M
-71.19%4.29M
Research and development costs
14.84%4.03M
1.04%680.63K
-11.56%874.82K
-9.98%967.89K
94.91%1.51M
381.90%3.51M
307.03%673.62K
316.65%989.17K
568.26%1.08M
369.18%775.34K
Other operating expenses
24.60%-83.33K
--0
---83.33K
----
----
---110.52K
---93.86K
----
----
---16.65K
Operating profit
19.75%-15.14M
29.80%-3.22M
34.46%-3.02M
32.67%-3.12M
-14.73%-5.78M
28.30%-18.86M
-14.44%-4.59M
-24.97%-4.61M
-30.19%-4.63M
66.54%-5.04M
Net non-operating interest income expense
4,640.71%552.29K
224.01%376.22K
313.82%61.67K
306.35%96.19K
162.79%18.22K
100.64%11.65K
154.31%116.12K
94.18%-28.84K
90.81%-46.61K
95.15%-29.01K
Non-operating interest income
4,640.71%552.29K
----
----
----
----
--11.65K
----
----
----
----
Total other finance cost
----
----
-313.82%-61.67K
-306.35%-96.19K
-162.79%-18.22K
----
----
--28.84K
--46.61K
--29.01K
Other net income (expense)
-52.49%169.66K
-84.53%19.24K
296.43%33.95K
39.81K
-69.34%76.66K
102.21%357.09K
124.37K
-17.28K
250K
Special income (charges)
--0
--0
--0
--0
--0
--250K
--0
--0
--0
--250K
-Less:Other special charges
----
----
----
----
----
---250K
--0
----
----
---250K
Other non- operating income (expenses)
58.43%169.66K
-84.53%19.24K
296.43%33.95K
--39.81K
--76.66K
100.66%107.09K
--124.37K
---17.28K
----
----
Income before tax
22.06%-14.42M
35.02%-2.83M
37.16%-2.93M
36.25%-2.98M
-18.02%-5.68M
58.25%-18.49M
78.69%-4.35M
-11.27%-4.66M
-15.08%-4.68M
69.23%-4.82M
Income tax
Net income
22.06%-14.42M
35.02%-2.83M
37.16%-2.93M
36.25%-2.98M
-18.02%-5.68M
58.25%-18.49M
78.69%-4.35M
-11.27%-4.66M
-15.08%-4.68M
69.23%-4.82M
Net income continuous Operations
22.06%-14.42M
35.02%-2.83M
37.16%-2.93M
36.25%-2.98M
-18.02%-5.68M
58.25%-18.49M
78.69%-4.35M
-11.27%-4.66M
-15.08%-4.68M
69.23%-4.82M
Minority interest income
Net income attributable to the parent company
22.06%-14.42M
35.02%-2.83M
37.16%-2.93M
36.25%-2.98M
-18.02%-5.68M
58.25%-18.49M
78.69%-4.35M
-11.27%-4.66M
-15.08%-4.68M
69.23%-4.82M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
22.06%-14.42M
35.02%-2.83M
37.16%-2.93M
36.25%-2.98M
-18.02%-5.68M
58.25%-18.49M
78.69%-4.35M
-11.27%-4.66M
-15.08%-4.68M
69.23%-4.82M
Basic earnings per share
33.07%-3.42
51.69%-0.57
50.00%-0.64
39.84%-0.77
-11.68%-1.53
86.30%-5.11
79.64%-1.18
74.37%-1.28
73.63%-1.28
93.05%-1.37
Diluted earnings per share
33.07%-3.42
51.69%-0.57
50.00%-0.64
39.84%-0.77
-11.68%-1.53
86.30%-5.11
79.64%-1.18
74.37%-1.28
73.63%-1.28
93.05%-1.37
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion
--
--
--
--
--
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 21.70%145.8K421.62%19.3K5.86%30.7K-9.28%64.5K95.63%31.3K160.43%119.8K-26.00%3.7K262.50%29K374.00%71.1K-11.11%16K
Operating revenue 21.70%145.8K421.62%19.3K5.86%30.7K-9.28%64.5K95.63%31.3K160.43%119.8K-26.00%3.7K262.50%29K374.00%71.1K-11.11%16K
Cost of revenue
Gross profit
Operating expense -19.49%15.28M-29.44%3.24M-34.21%3.05M-32.31%3.18M14.99%5.81M-27.97%18.98M14.39%4.59M25.48%4.64M31.64%4.7M-66.47%5.05M
Selling and administrative expenses -27.27%11.33M-36.21%2.56M-38.07%2.26M-38.94%2.21M0.11%4.3M-39.20%15.58M4.24%4.01M5.50%3.65M6.31%3.62M-71.19%4.29M
-General and administrative expense -27.27%11.33M-36.21%2.56M-38.07%2.26M-38.94%2.21M0.11%4.3M-39.20%15.58M4.24%4.01M5.50%3.65M6.50%3.62M-71.19%4.29M
Research and development costs 14.84%4.03M1.04%680.63K-11.56%874.82K-9.98%967.89K94.91%1.51M381.90%3.51M307.03%673.62K316.65%989.17K568.26%1.08M369.18%775.34K
Other operating expenses 24.60%-83.33K--0---83.33K-----------110.52K---93.86K-----------16.65K
Operating profit 19.75%-15.14M29.80%-3.22M34.46%-3.02M32.67%-3.12M-14.73%-5.78M28.30%-18.86M-14.44%-4.59M-24.97%-4.61M-30.19%-4.63M66.54%-5.04M
Net non-operating interest income expense 4,640.71%552.29K224.01%376.22K313.82%61.67K306.35%96.19K162.79%18.22K100.64%11.65K154.31%116.12K94.18%-28.84K90.81%-46.61K95.15%-29.01K
Non-operating interest income 4,640.71%552.29K------------------11.65K----------------
Total other finance cost ---------313.82%-61.67K-306.35%-96.19K-162.79%-18.22K----------28.84K--46.61K--29.01K
Other net income (expense) -52.49%169.66K-84.53%19.24K296.43%33.95K39.81K-69.34%76.66K102.21%357.09K124.37K-17.28K250K
Special income (charges) --0--0--0--0--0--250K--0--0--0--250K
-Less:Other special charges -----------------------250K--0-----------250K
Other non- operating income (expenses) 58.43%169.66K-84.53%19.24K296.43%33.95K--39.81K--76.66K100.66%107.09K--124.37K---17.28K--------
Income before tax 22.06%-14.42M35.02%-2.83M37.16%-2.93M36.25%-2.98M-18.02%-5.68M58.25%-18.49M78.69%-4.35M-11.27%-4.66M-15.08%-4.68M69.23%-4.82M
Income tax
Net income 22.06%-14.42M35.02%-2.83M37.16%-2.93M36.25%-2.98M-18.02%-5.68M58.25%-18.49M78.69%-4.35M-11.27%-4.66M-15.08%-4.68M69.23%-4.82M
Net income continuous Operations 22.06%-14.42M35.02%-2.83M37.16%-2.93M36.25%-2.98M-18.02%-5.68M58.25%-18.49M78.69%-4.35M-11.27%-4.66M-15.08%-4.68M69.23%-4.82M
Minority interest income
Net income attributable to the parent company 22.06%-14.42M35.02%-2.83M37.16%-2.93M36.25%-2.98M-18.02%-5.68M58.25%-18.49M78.69%-4.35M-11.27%-4.66M-15.08%-4.68M69.23%-4.82M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 22.06%-14.42M35.02%-2.83M37.16%-2.93M36.25%-2.98M-18.02%-5.68M58.25%-18.49M78.69%-4.35M-11.27%-4.66M-15.08%-4.68M69.23%-4.82M
Basic earnings per share 33.07%-3.4251.69%-0.5750.00%-0.6439.84%-0.77-11.68%-1.5386.30%-5.1179.64%-1.1874.37%-1.2873.63%-1.2893.05%-1.37
Diluted earnings per share 33.07%-3.4251.69%-0.5750.00%-0.6439.84%-0.77-11.68%-1.5386.30%-5.1179.64%-1.1874.37%-1.2873.63%-1.2893.05%-1.37
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion------------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg